Seeing Is Believing

Currently out of the existing stock ratings of Yi Chen, 516 are a BUY (91.01%), 49 are a HOLD (8.64%), 2 are a SELL (0.35%).
Analyst Yi Chen, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 37.33% that have a potential upside of 49.65% achieved within 224 days.
Yi Chen’s has documented 1,073 price targets and ratings displayed on 56 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on GLSI, Greenwich Lifesciences at 30-Dec-2025.
Analyst best performing recommendations are on CELC (CELCUITY LLC).
The best stock recommendation documented was for VERU (VERU) at 12/10/2020. The price target of $80 was fulfilled within 4 days with a profit of $20.3 (34%) receiving and performance score of 85.01.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
1 years 8 months 1 days ago
(03-May-2024)
2/5 (40%)
$13.4 (372.22%)
248
Buy
$15
1 years 9 months 22 days ago
(13-Mar-2024)
1/9 (11.11%)
$11.06 (280.71%)
11
Which stock is Yi Chen is most bullish on?
Which stock is Yi Chen is most reserved on?
What Year was the first public recommendation made by Yi Chen?